QuiaPEG Pharmaceuticals Holding AB (publ), a biotech company, develops biopharmaceutical products for the treatment of metabolic disorders. It develops biopharmaceuticals based on PEGylation technology platform, which is applicable on proteins, peptides, and small molecules or oligonucleotides. The company has strategic collaboration with Cobra Biologics AB for the refinement of biopharmaceutical products. The company was formerly known as Oligovation AB and changed its name to QuiaPEG Pharmaceuticals Holding AB (publ). QuiaPEG Pharmaceuticals Holding AB (publ) was founded in 2012 and is headquartered in Solna, Sweden.
QuiaPEG Pharmaceuticals Dividend Announcement
• QuiaPEG Pharmaceuticals announced a semi annually dividend of kr2.39 per ordinary share which will be made payable on 2017-04-05. Ex dividend date: 2017-03-30
• QuiaPEG Pharmaceuticals's trailing twelve-month (TTM) dividend yield is -%
QuiaPEG Pharmaceuticals Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2017-03-30 | kr2.39 | semi annually | 2017-04-05 |
2017-03-06 | kr0.13 | semi annually | 2017-03-10 |
2016-06-09 | kr0.26 | semi annually | |
2014-05-07 | kr0.11 | semi annually | |
2013-04-26 | kr0.22 | semi annually | |
2012-04-27 | kr0.22 | semi annually |
QuiaPEG Pharmaceuticals Dividend per year
QuiaPEG Pharmaceuticals Dividend growth
QuiaPEG Pharmaceuticals Dividend Yield
QuiaPEG Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing QuiaPEG Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:
QuiaPEG Pharmaceuticals Financial Ratios
QuiaPEG Pharmaceuticals Dividend FAQ
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy QuiaPEG Pharmaceuticals stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.